Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
Sponsor: Merck Sharp & Dohme LLC
Summary
The primary objective of this study is to compare belzutifan to everolimus with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) and to compare everolimus with respect to overall survival (OS). The hypothesis is that belzutifan is superior to everolimus with respect to PFS and OS.
Official title: An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants With Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
755
Start Date
2020-02-27
Completion Date
2026-10-14
Last Updated
2026-10-20
Healthy Volunteers
No
Conditions
Interventions
Belzutifan
Oral tablets
Everolimus
Oral tablets
Locations (172)
Faculty Office Towers 1132 ( Site 1538)
Birmingham, Alabama, United States
University of California San Diego Moores Cancer Center ( Site 1546)
La Jolla, California, United States
St. Joseph Heritage Healthcare Local Lab ( Site 1531)
Santa Rosa, California, United States
University of Colorado Cancer Center ( Site 1540)
Aurora, Colorado, United States
UCHealth Highlands Ranch Hospital ( Site 1560)
Highlands Ranch, Colorado, United States
Sibley Memorial Hospital ( Site 1559)
Washington D.C., District of Columbia, United States
Northwest Georgia Oncology Centers PC ( Site 1520)
Marietta, Georgia, United States
The University of Chicago Medical Center ( Site 1539)
Chicago, Illinois, United States
Ochsner Medical Center ( Site 1522)
New Orleans, Louisiana, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 1514)
Baltimore, Maryland, United States
Massachusetts General Hospital ( Site 1558)
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center ( Site 1501)
Boston, Massachusetts, United States
Dana Farber Cancer Institute ( Site 1505)
Boston, Massachusetts, United States
Henry Ford Cancer Center ( Site 1511)
Detroit, Michigan, United States
Hattiesburg Clinic ( Site 1509)
Hattiesburg, Mississippi, United States
St. Vincent Frontier Cancer Center ( Site 1549)
Billings, Montana, United States
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1513)
Hackensack, New Jersey, United States
University of Rochester Medical Center ( Site 1543)
Rochester, New York, United States
University of North Carolina at Chapel Hill ( Site 1537)
Chapel Hill, North Carolina, United States
Oncology Hematology Care, Inc. ( Site 1524)
Cincinnati, Ohio, United States
Cleveland Clinic Main ( Site 1504)
Cleveland, Ohio, United States
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 1523)
Tulsa, Oklahoma, United States
Oregon Health & Science University ( Site 1553)
Portland, Oregon, United States
Abramson Cancer Center ( Site 1525)
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center ( Site 1506)
Philadelphia, Pennsylvania, United States
Medical University of South Carolina ( Site 1518)
Charleston, South Carolina, United States
Henry Joyce Cancer Clinic ( Site 1544)
Nashville, Tennessee, United States
Texas Oncology-Austin Central ( Site 1533)
Austin, Texas, United States
Texas Oncology, P.A.-Dallas ( Site 1534)
Dallas, Texas, United States
Centro Avançado de Tratamento Oncológico- CENANTRON ( Site 1657)
Belo Horizonte, Minas Gerais, Brazil
Instituto de Cancer e Transplante de Curitiba ICTR ( Site 1650)
Curitiba, Paraná, Brazil
Liga Norte Riograndense Contra o Cancer ( Site 1651)
Natal, Rio Grande do Norte, Brazil
Hospital de Clinicas de Porto Alegre ( Site 1655)
Porto Alegre, Rio Grande do Sul, Brazil
BP - A Beneficencia Portuguesa de São Paulo ( Site 1653)
São Paulo, São Paulo, Brazil
BC Cancer - Vancouver Center ( Site 0155)
Vancouver, British Columbia, Canada
Nova Scotia Health Authority QEII-HSC ( Site 0150)
Halifax, Nova Scotia, Canada
Juravinski Cancer Centre ( Site 0154)
Hamilton, Ontario, Canada
Sunnybrook Research Institute ( Site 0153)
Toronto, Ontario, Canada
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0151)
Montreal, Quebec, Canada
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0152)
Québec, Quebec, Canada
Centro Investigación del Cáncer James Lind ( Site 0004)
Temuco, Araucania, Chile
Bradfordhill ( Site 0003)
Santiago, Region M. de Santiago, Chile
Fundacion Centro de Investigacion Clinica CIC ( Site 1703)
Medellín, Antioquia, Colombia
Administradora Country SA - Clinica del Country ( Site 1701)
Bogotá, Bogota D.C., Colombia
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1702)
Bogotá, Bogota D.C., Colombia
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1709)
Valledupar, Cesar Department, Colombia
Oncologos del Occidente S.A. ( Site 1708)
Pereira, Risaralda Department, Colombia
Masarykuv onkologicky ustav ( Site 0105)
Brno, Brno-mesto, Czechia
Fakultni nemocnice Ostrava ( Site 0103)
Ostrava, Ostrava Mesto, Czechia
Fakultni nemocnice Hradec Kralove ( Site 0106)
Hradec Králové, Czechia
Fakultni nemocnice Olomouc ( Site 0104)
Olomouc, Czechia
Fakultni nemocnice Kralovske Vinohrady ( Site 0102)
Prague, Czechia
Fakultni Thomayerova nemocnice ( Site 0107)
Prague, Czechia
Herlev Hospital ( Site 0251)
Herlev, Capital Region, Denmark
Aarhus University Hospital Skejby ( Site 0250)
Aarhus, Central Jutland, Denmark
Kuopion Yliopistollinen Sairaala ( Site 0304)
Kuopio, Northern Savonia, Finland
Tampereen yliopistollinen sairaala ( Site 0300)
Tampere, Pirkanmaa, Finland
TYKS T-sairaala Syopatautien pkl ( Site 0301)
Turku, Southwest Finland, Finland
HYKS. ( Site 0302)
Helsinki, Uusimaa, Finland
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0350)
Strasbourg, Alsace, France
CHU de Bordeaux Hop St ANDRE ( Site 0359)
Bordeaux, Aquitaine, France
Centre Francois Baclesse ( Site 0360)
Caen, Calvados, France
CHU Besancon - Hopital Jean Minjoz ( Site 0351)
Besançon, Doubs, France
Institut de Cancerologie du Gard - CHU Caremeau ( Site 0352)
Nîmes, Gard, France
Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 0356)
Vandœuvre-lès-Nancy, Lorraine, France
Centre Hospitalier Lyon Sud ( Site 0354)
Pierre-Bénite, Rhone, France
Gustave Roussy ( Site 0353)
Villejuif, Val-de-Marne, France
Universitaetsklinik fuer Urologie ( Site 0405)
Tübingen, Baden-Wurttemberg, Germany
Universitaetsklinikum Duesseldorf ( Site 0410)
Düsseldorf, North Rhine-Westphalia, Germany
Universitaetsklinikum Essen ( Site 0401)
Essen, North Rhine-Westphalia, Germany
Universitaetsklinikum Carl Gustav Carus Dresden ( Site 0403)
Dresden, Saxony, Germany
Universitaetsklinikum Magdeburg A.o.R. ( Site 0404)
Magdeburg, Saxony-Anhalt, Germany
Universitaetsklinikum Jena ( Site 0402)
Jena, Thuringia, Germany
Universitaetsmedizin Berlin ( Site 0400)
Berlin, Germany
Universitatsklinikum Hamburg ( Site 0408)
Hamburg, Germany
Queen Mary Hospital ( Site 1051)
Hong Kong, Hong Kong
Prince of Wales Hospital ( Site 1050)
Hong Kong, Hong Kong
Queen Elizabeth Hospital. ( Site 1052)
Kowloon, Hong Kong
Princess Margaret Hospital. ( Site 1053)
Lai Chi Kok, Hong Kong
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 0505)
Gyula, Bekes County, Hungary
Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás Ce ( Site 0502)
Miskolc, Borsod-Abauj Zemplen county, Hungary
Debreceni Egyetem Klinikai Kozpont ( Site 0504)
Debrecen, Hajdú-Bihar, Hungary
Semmelweis Egyetem ( Site 0501)
Budapest, Hungary
Orszagos Onkologiai Intezet ( Site 0503)
Budapest, Hungary
Zala Megyei Szent Rafael Korhaz ( Site 0509)
Zalaegerszeg, Hungary
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento-Oncology Unit ( Site 0605)
Verona, Veneto, Italy
Medical Oncology Ospedale San Donato ( Site 0609)
Arezzo, Italy
Azienda Ospedaliera Policlinico di Bari ( Site 0610)
Bari, Italy
AOU di Bologna Policlinico S Orsola Malpighi ( Site 0606)
Bologna, Italy
Istituto Nazionale dei Tumori ( Site 0601)
Milan, Italy
Azienda Ospedaliero Universitaria di Modena Policlinico ( Site 0604)
Modena, Italy
Istituto Oncologico Veneto IRCCS ( Site 0603)
Padova, Italy
Fondazione Salvatore Maugeri clinica del lavoro ( Site 0600)
Pavia, Italy
Fondazione Policlinico Universitario A. Gemelli ( Site 0607)
Roma, Italy
Azienda Ospedaliera Santa Maria ( Site 0602)
Terni, Italy
Fujita Health University Hospital ( Site 1016)
Toyoake, Aichi-ken, Japan
National Cancer Center Hospital East ( Site 1001)
Kashiwa, Chiba, Japan
Ehime University Hospital ( Site 1014)
Tōon, Ehime, Japan
Sapporo Medical University Hospital ( Site 1008)
Sapporo, Hokkaido, Japan
Yokohama City University Hospital ( Site 1015)
Yokohama, Kanagawa, Japan